Literature DB >> 30272222

ANALYTICAL MODEL TO ESTIMATE EQUIVALENT DOSE FROM INTERNAL NEUTRONS IN PROTON THERAPY OF CHILDREN WITH INTRACRANIAL TUMORS.

Kyle J Gallagher1,2, Phillip J Taddei3,4.   

Abstract

This study developed a computationally efficient and easy-to-implement analytical model to estimate the equivalent dose from secondary neutrons originating in the bodies ('internal neutrons') of children receiving intracranial proton radiotherapy. A two-term double-Gaussian mathematical model was fit to previously published internal neutron equivalent dose per therapeutic absorbed dose versus distance from the field edge calculated using Monte Carlo simulations. The model was trained using three intracranial proton fields of a 9-year-old girl. The resulting model was tested against two intracranial fields of a 10-year-old boy by comparing the mean doses in organs at risk of a radiogenic cancer estimated by the model versus those previously calculated by Monte Carlo. On average, the model reproduced the internal neutron organ doses in the 10-year-old boy within 13.5% of the Monte Carlo at 3-10 cm from the field edge and within a factor of 2 of the Monte Carlo at 10-20 cm from the field edge. Beyond 20 cm, the model poorly estimated H/DRx, however, the values were very small, at <0.03 mSv Gy-1.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 30272222      PMCID: PMC6596440          DOI: 10.1093/rpd/ncy166

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  34 in total

1.  Neutron RBE for induction of tumors with high lethality in Sprague-Dawley rats.

Authors:  C Wolf; J Lafuma; R Masse; M Morin; A M Kellerer
Journal:  Radiat Res       Date:  2000-10       Impact factor: 2.841

2.  Design tools for proton therapy nozzles based on the double-scattering foil technique.

Authors:  J D Fontenot; W D Newhauser; U Titt
Journal:  Radiat Prot Dosimetry       Date:  2005       Impact factor: 0.972

3.  Out-of-field dose equivalents delivered by proton therapy of prostate cancer.

Authors:  Andrew Wroe; Anatoly Rosenfeld; Reinhard Schulte
Journal:  Med Phys       Date:  2007-09       Impact factor: 4.071

4.  The comparative tumorigenic effects of fission neutrons and cobalt-60 gamma rays in the B6CF1 mouse.

Authors:  D Grahn; L S Lombard; B A Carnes
Journal:  Radiat Res       Date:  1992-01       Impact factor: 2.841

5.  Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.

Authors:  D J Brenner; R E Curtis; E J Hall; E Ron
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

6.  Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer.

Authors:  Jonas Fontenot; Phillip Taddei; Yuanshui Zheng; Dragan Mirkovic; Thomas Jordan; Wayne Newhauser
Journal:  Phys Med Biol       Date:  2008-02-29       Impact factor: 3.609

7.  Tumorigenesis in high-dose total body irradiated rhesus monkeys--a life span study.

Authors:  Carel F Hollander; Chris Zurcher; Johan J Broerse
Journal:  Toxicol Pathol       Date:  2003 Mar-Apr       Impact factor: 1.902

8.  Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.

Authors:  Christina Zacharatou Jarlskog; Choonik Lee; Wesley E Bolch; X George Xu; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-01-10       Impact factor: 3.609

9.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

10.  The risk of developing a second cancer after receiving craniospinal proton irradiation.

Authors:  Wayne D Newhauser; Jonas D Fontenot; Anita Mahajan; David Kornguth; Marilyn Stovall; Yuanshui Zheng; Phillip J Taddei; Dragan Mirkovic; Radhe Mohan; James D Cox; Shiao Woo
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

View more
  3 in total

Review 1.  Neutron dose and its measurement in proton therapy-current State of Knowledge.

Authors:  Roger Antoine Hälg; Uwe Schneider
Journal:  Br J Radiol       Date:  2020-01-21       Impact factor: 3.039

Review 2.  Determining Out-of-Field Doses and Second Cancer Risk From Proton Therapy in Young Patients-An Overview.

Authors:  Maite Romero-Expósito; Iuliana Toma-Dasu; Alexandru Dasu
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

3.  Proton Radiotherapy Could Reduce the Risk of Fatal Second Cancers for Children with Intracranial Tumors in Low- and Middle-Income Countries.

Authors:  Kyle J Gallagher; Bassem Youssef; Rola Georges; Anita Mahajan; Joelle Ann Feghali; Racile Nabha; Zeina Ayoub; Wassim Jalbout; Phillip J Taddei
Journal:  Int J Part Ther       Date:  2021-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.